Search results

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

26 August 2015

Evidence-based recommendations on edoxaban (Lixiana) for treating and preventing deep vein thrombosis (DVT) and pulmonary embolism

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

22 July 2015

Evidence-based recommendations on aflibercept (Eylea) for treating diabetic macular oedema

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

16 December 2015

Evidence-based recommendations on bortezomib (Velcade) for treating previously untreated mantle cell lymphoma in adults

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

26 August 2015

Evidence-based recommendations on vedolizumab (Entyvio) for moderately to severely active Crohn's disease if TNF-alpha therapy has not worked or...

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

22 July 2015

NICE is unable to make recommendations about the use of cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary…

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

22 July 2015

Evidence-based recommendations on naloxegol (Moventig) for treating opioid-induced constipation that has had inadequate response to laxatives

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

22 July 2015

Evidence-based recommendations on everolimus (Certican) for preventing organ rejection in people having a liver transplant

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

07 October 2015

Evidence-based recommendations on pembrolizumab (Keytruda) for treating advanced melanoma after disease progression with ipilimumab in adults

Read Summary

SPS comment

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

12 December 2018

Evidence-based recommendations on vandetanib (Caprelsa) for treating medullary thyroid cancer in adults

Read Summary

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)

Source:

National Institute for Health and Care Excellence - NICE (Remove filter)

14 November 2018

Evidence-based recommendations on emtuzumab oxogamicin (Mylotarg) for untreated acute myeloid leukaemia (AML) in people aged 15 years and over

Read Summary

SPS comment

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Remove filter)